Advertisement ACADIA Pharmaceuticals, CombinatoRx, MediGene AG and Midas Pharma - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Brainloop

Secure Document Management for Confidential Documents

More info about Brainloop

ACADIA Pharmaceuticals, CombinatoRx, MediGene AG and Midas Pharma

CASE STUDIES
By Brainloop

Case studies from ACADIA Pharmaceuticals, CombinatoRx, MediGene AG and Midas Pharma.

ACADIA Pharmaceuticals

ACADIA Pharmaceuticals is a biopharmaceutical company utilising innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders.

Simon Craw, senior director of Information Systems and IT, ACADIA Pharmaceuticals, San Diego, CA, said: “We chose Brainloop because of the product’s unique ability to provide secure viewing and auditing functionality down to the page level. The security model is well thought through, adding users and sharing documents simpley and securely. Reporting is easy to use yet powerful enough to provide meaningful insight.”

CombinatoRx, Incorporated

CombinatoRx, Incorporated is pioneering the new field of synergistic combination pharmaceuticals. Going beyond traditional combinations, CombinatoRx creates product candidates with novel mechanisms of action striking at the biological complexities of human disease.

Richard Brudnick, vice president of Business Development, CombinatoRx Inc., Cambridge, MA, said: “It was very easy to set up, and being able to share and protect files so easily really boosts efficiency. Plus, the support team has been terrific about responding to questions quickly.”

MediGene AG

MediGene AG is a publicly listed (Frankfurt, Prime Standard: MDG, TecDAX) biotechnology company located in Martinsried / Munich, Germany, with subsidiaries in Oxford, UK and San Diego, US. MediGene is the first German biotech company to have drugs on the market, which are being distributed by partner companies. MediGene has several drug candidates in clinical development, including EndoTAG?-1, which could offer substantial sales returns.

Dr Markus Hörer, director Research & Analytics, MediGene AG, said: “The Brainloop Secure Dataroom allows us to quickly exchange highly confidential information, such as current research results, reports and patent registrations with our collaboration partners on a revocable basis. At the same time, we can the secure document ownership in a controlled and supervised environment.”

Midas Pharma

As an independent marketing and sales company Midas Pharma brings together companies with different interests and capabilities. The objective: To be the partner of first choice for manufacturers and clients in all questions concerning active pharmaceutical ingredients, custom synthesis, pharmaceutical contract manufacture, international licensing or registration dossiers.

Dr Marcus Stumpf, managing director, Midas Pharma GmbH, said: “The Brainloop Secure Dataroom helps us to distribute highly secure information to our partners in a safe, simple and user-friendly manner. Intelligent security categories and traceability allow us to precisely monitor who has done what with the documents and when.”